Nila Rafiq - Concepedia

Author

Nila Rafiq

Inova Health System

Also Known As

N. Rafiq, NILA RAFIQ, Nila Rafiq, Noor Fatima Rafiq, Rafiq, N.

Publications

Citations

H-Index

Concepts

All Affiliations

Inova Health System Inova Fairfax Hospital Center for Outcomes Research in Liver Diseases Armed Forces Institute of Pathology George Mason University

About

Nila Rafiq is an author at Inova Health System specializing in medicine, hepatology, and metabolic associated steatohepatitis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	9	3.9K
2	Health Sciences	7	8	2.7K
3	Epidemiology	3	3	906
4	Diabetes	1	1	273
5	Gastroenterology	1	1	64

Nila Rafiq

Publications

5.4K

Citations

H-Index

Page 1

	Year	Citations
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial Zobair M. Younossi, Vlad Ratziu, Rohit Loomba, The Lancet Interim AnalysisMetabolic Associated SteatohepatitisHepatologyPlacebo-controlled Phase 3Nonalcoholic Fatty Liver Disease	2019	1.2K
Long-Term Follow-Up of Patients With Nonalcoholic Fatty Liver Nila Rafiq, Chunhong Bai, Yun Fang, Clinical Gastroenterology and Hepatology ObesityMetabolic Associated SteatohepatitisHepatologyNonalcoholic Fatty Liver DiseaseMedicine	2008	733
Pathologic criteria for nonalcoholic steatohepatitis: Interprotocol agreement and ability to predict liver-related mortality Zobair M. Younossi, Maria Stepanova, Nila Rafiq, Hepatology	2011	621
Epidemiology of chronic liver diseases in the USA in the past three decades Zobair M. Younossi, Maria Stepanova, Youssef Younossi, Gut	2019	535
Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials Stephen A. Harrison, Vincent Wai‐Sun Wong, Takeshi Okanoue, Journal of Hepatology FibrosisHepatologyLiver PhysiologyClinical TrialsPathology	2020	438
Independent Predictors of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Noreen Hossain, Arian Afendy, Maria Stepanova, Clinical Gastroenterology and Hepatology ObesityMetabolic SyndromeMetabolic Associated SteatohepatitisFibrosisHepatology	2009	339
Components of metabolic syndrome are independent predictors of mortality in patients with chronic liver disease: a population-based study Maria Stepanova, Nila Rafiq, Zobair M. Younossi Gut	2010	301
Predictors of All-Cause Mortality and Liver-Related Mortality in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD) Maria Stepanova, Nila Rafiq, Hala R. Makhlouf, Digestive Diseases and Sciences ObesityMetabolic SyndromeAll-cause MortalityMetabolic Associated SteatohepatitisHepatology	2013	294
A Novel Diagnostic Biomarker Panel for Obesity-related Nonalcoholic Steatohepatitis (NASH) Zobair M. Younossi, Mohammed Jarrar, Clare Nugent, Obesity Surgery ObesityMetabolic SyndromeMetabolic Associated SteatohepatitisMetabolic Associated Steatotic Liver DiseaseNonalcoholic Fatty Liver Disease	2008	273
Components of metabolic syndrome increase the risk of mortality in nonalcoholic fatty liver disease (NAFLD) Pegah Golabi, Munkhzul Otgonsuren, Leyla de Avila, Medicine	2018	206

Page 1